Pantoprazole Eg (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on gastric acid‑secreting pathways.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive esophagitis: accelerates healing of erosive lesions in the oesophagus.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

• Pantoprazole selectively inhibits the H⁺/K⁺‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Abdominal pain: occasional discomfort.
• Nausea: transient feeling of queasiness.
• Flatulence: excess gas in the gastrointestinal tract.
• Constipation: infrequent bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis requiring medical attention.
• Acute interstitial nephritis: kidney inflammation presenting with reduced urine output.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Osteoporotic fractures: increased risk with long‑term use.
• Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia.

When prescribing Pantoprazole, consider patient‑specific factors and monitor for potential issues.

• Renal impairment: adjust monitoring if kidney function is reduced.
• Hepatic impairment: use caution in patients with liver disease.
• Long‑term therapy: evaluate need periodically to avoid unnecessary exposure.
• Pregnancy and lactation: weigh benefits against potential risks; consult guidelines.
• Drug interactions: review concomitant medications for possible PK/PD effects.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to higher gastric pH.
• HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation parameters.
• Methotrexate: reduced clearance may raise toxicity risk.
• Digoxin: slight increase in serum levels; observe for signs of toxicity.
• Clopidogrel: potential reduction in antiplatelet effect; consider alternative therapy.